The potential use of this vaccine was thus postponed until the last quarter of 2021.
–
“We care a lot about public health, so we are disappointed with the announced delay. But all our decisions are and will always be guided by science and concrete data, ”said Sanofi spokesman Thomas Triomphe.
–
The media described the Sanofi and GSK statements as a blow to contractors, including the EU, the US, Canada and Britain, who had booked hundreds of millions of benefits in an effort to halt the covidu-19 pandemic. For example, the European Commission has ordered 300 million specimens from Sanofi and GSK.
–
Meanwhile, the Pfizer / BioNTech vaccine continues its successful campaign, and its deployment was supported on Thursday by a commission of independent advisers from the US Food and Drug Administration (FDA). It is expected that the FDA itself will approve it in the coming days, and that the first health care providers and nurses could be vaccinated next week.
–
The Pfizer / BioNTech vaccine has also been newly approved by Saudi Arabia and has also been registered by Mexico. According to current information, the European Medicines Agency will recommend conditional marketing authorization for the product to the European Commission no earlier than 29 December.
–
Australia has stopped development
Meanwhile, the Australian company CSL stopped developing its vaccine due to the fact that some participants in the study had false positive tests for the HIV virus. The Australian government originally wanted to buy 51 million doses from the company, but instead will buy more foreign preparations.
–
The Australian vaccine went through the first phase of testing and was perceived as promising because a large number of antibodies formed in the test subjects’ bodies.
–
It would allegedly take a year to correct the mistake, which led to the decision to abandon its development.
—
